Cargando…

Path to Clonal Theranostics in Luminal Breast Cancers

Integrating tumor heterogeneity in the drug discovery process is a key challenge to tackle breast cancer resistance. Identifying protein targets for functionally distinct tumor clones is particularly important to tailor therapy to the heterogeneous tumor subpopulations and achieve clonal theranostic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hajjaji, Nawale, Aboulouard, Soulaimane, Cardon, Tristan, Bertin, Delphine, Robin, Yves-Marie, Fournier, Isabelle, Salzet, Michel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793283/ https://www.ncbi.nlm.nih.gov/pubmed/35096604 http://dx.doi.org/10.3389/fonc.2021.802177

Ejemplares similares

Surfaceome Proteomic of Glioblastoma Revealed Potential Targets for Immunotherapy
por: Rose, Mélanie, et al.
Publicado: (2021)

Fallopian tube lesions as potential precursors of early ovarian cancer: a comprehensive proteomic analysis
por: Wisztorski, Maxence, et al.
Publicado: (2023)

Should a Multigene Signature be Used in all Luminal Early Breast Cancers
por: Hajjaji, Nawale, et al.
Publicado: (2019)

Establishment and characterization of canine mammary tumoroids for translational research
por: Raffo-Romero, Antonella, et al.
Publicado: (2023)

Reference and Ghost Proteins Identification in Rat C6 Glioma Extracellular Vesicles
por: Murgoci, Adriana-Natalia, et al.
Publicado: (2020)

Epigenetic Studies Revealed a Ghost Proteome in PC1/3 KD Macrophages under Antitumoral Resistance Induced by IL-10
por: Cardon, Tristan, et al.
Publicado: (2020)

In-depth proteomics analysis of sentinel lymph nodes from individuals with endometrial cancer
por: Aboulouard, Soulaimane, et al.
Publicado: (2021)

Therapeutic anti-glioma effect of the combined action of PCSK inhibitor with the anti-tumoral factors secreted by Poly (I:C)-stimulated macrophages
por: Rose, Mélanie, et al.
Publicado: (2021)

SARS-Cov-2 Interactome with Human Ghost Proteome: A Neglected World Encompassing a Wealth of Biological Data
por: Cardon, Tristan, et al.
Publicado: (2020)

Unveiling a Ghost Proteome in the Glioblastoma Non-Coding RNAs
por: Cardon, Tristan, et al.
Publicado: (2021)

The Role of a Proprotein Convertase Inhibitor in Reactivation of Tumor-Associated Macrophages and Inhibition of Glioma Growth
por: Rose, Mélanie, et al.
Publicado: (2020)

Spatial analysis of the glioblastoma proteome reveals specific molecular signatures and markers of survival
por: Duhamel, Marie, et al.
Publicado: (2022)

Correction: Heimdall, an alternative protein issued from a ncRNA related to kappa light chain variable region of immunoglobulins from astrocytes: a new player in neural proteome
por: Capuz, Alice, et al.
Publicado: (2023)

Heimdall, an alternative protein issued from a ncRNA related to kappa light chain variable region of immunoglobulins from astrocytes: a new player in neural proteome
por: Capuz, Alice, et al.
Publicado: (2023)

Protocol to identify human subcellular alternative protein interactions using cross-linking mass spectrometry
por: Garcia-del Rio, Diego Fernando, et al.
Publicado: (2023)

Location of neonatal microglia drives small extracellular vesicles content and biological functions in vitro
por: Murgoci, Adriana-Natalia, et al.
Publicado: (2020)

Employing non-targeted interactomics approach and subcellular fractionation to increase our understanding of the ghost proteome
por: Garcia-del Rio, Diego Fernando, et al.
Publicado: (2023)

Ovarian Cancer Targeted Theranostics
por: Nimmagadda, Sridhar, et al.
Publicado: (2020)

16 Months Follow Up of Patients’ Behavior and Mild COVID-19 Patterns in a Large Cohort of Cancer Patients During the Pandemic
por: Hajjaji, Nawale, et al.
Publicado: (2022)

Protein Kinase C Activation Drives a Differentiation Program in an Oligodendroglial Precursor Model through the Modulation of Specific Biological Networks
por: Damato, Marina, et al.
Publicado: (2021)

Nanozymes in Tumor Theranostics
por: Ma, Qiulian, et al.
Publicado: (2021)

Alternative proteins are functional regulators in cell reprogramming by PKA activation
por: Cardon, Tristan, et al.
Publicado: (2020)

Development and validation of an ultrasound-based radiomics nomogram for predicting the luminal from non-luminal type in patients with breast carcinoma
por: Wu, Jiangfeng, et al.
Publicado: (2022)

Prostate Cancer Theranostics - An Overview
por: Abou, Diane, et al.
Publicado: (2020)

Theranostic digital twins for personalized radiopharmaceutical therapies: Reimagining theranostics via computational nuclear oncology
por: Rahmim, Arman, et al.
Publicado: (2022)

Mass spectrometry-based intraoperative tumor diagnostics: a letter in reply
por: Fournier, Isabelle, et al.
Publicado: (2019)

ALK4/5-dependent TGF-β signaling contributes to the crosstalk between neurons and microglia following axonal lesion
por: Raffo-Romero, Antonella, et al.
Publicado: (2019)

Astrocytes express aberrant immunoglobulins as putative gatekeeper of astrocytes to neuronal progenitor conversion
por: Capuz, Alice, et al.
Publicado: (2023)

Hormonal Receptor Immunochemistry Heterogeneity and (18)F-FDG Metabolic Heterogeneity: Preliminary Results of Their Relationship and Prognostic Value in Luminal Non-Metastatic Breast Cancers
por: Aide, Nicolas, et al.
Publicado: (2021)

Comprehensive proteome, phosphoproteome and kinome characterization of luminal A breast cancer
por: Yang, Ganglong, et al.
Publicado: (2023)

Clinical advancement of precision theranostics in prostate cancer
por: Tan, Yue, et al.
Publicado: (2023)

MicroRNAs Role in Breast Cancer: Theranostic Application in Saudi Arabia
por: Alyami, Nouf M.
Publicado: (2021)

Fibroblast activation protein-based theranostics in pancreatic cancer
por: Cheng, Chien-shan, et al.
Publicado: (2022)

Editorial: Radiomics-based theranostics in cancer precision medicine
por: Ji, Jiansong, et al.
Publicado: (2023)

SIRT7 Is a Prognostic Biomarker Associated With Immune Infiltration in Luminal Breast Cancer
por: Huo, Qin, et al.
Publicado: (2020)

RNA m(6)A Methylation Regulators Subclassify Luminal Subtype in Breast Cancer
por: Yang, Lin, et al.
Publicado: (2021)

Mechanical Properties in the Glioma Microenvironment: Emerging Insights and Theranostic Opportunities
por: Bhargav, Adip G., et al.
Publicado: (2022)

Theranostic Pretargeting Drug Delivery and Imaging Platforms in Cancer Precision Medicine
por: Hapuarachchige, Sudath, et al.
Publicado: (2020)

Biomimetic Nanoparticles Camouflaged in Cancer Cell Membranes and Their Applications in Cancer Theranostics
por: Jin, Jiefu, et al.
Publicado: (2020)

The Current Status and Future Potential of Theranostics to Diagnose and Treat Childhood Cancer
por: Poot, Alex J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5m9cp03e63i3n1s8fgmvb7mdfd